Enfermedad de Parkinson, información, noticias, tratamientos, fármacos, investigación, terapias.

Science Daily

Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
  1. Telemedicine can successfully deliver quality care, new findings from a nationwide program that links neurologists with patients with Parkinson's disease in their homes via video conferencing shows. The study points to a new way to improve care for people who suffer from the disease, but may have not have access to a neurologist.
  2. A drug commonly used to treat diabetes may have disease-modifying potential to treat Parkinson's disease, a new study suggests, paving the way for further research to define its efficacy and safety.
  3. A music therapy class is helping people with Parkinson's disease build strength through song. A new study shows singing improves the muscles used for swallowing and respiratory control -- two functions complicated by Parkinson's.
  4. Researchers have developed a new drug that may limit the progression of Parkinson's disease while providing better symptom relief to potentially hundreds of thousands of people with the disease.
  5. Scientists have discovered a new method of observing the brain changes caused by Parkinson's disease, which destroys neurons important for movement. The development suggests that fluid changes in a specific brain area could provide a way to track that damage.
  6. Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson's and Alzheimer's diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance.
  7. Changes in the visual systems of newly diagnosed Parkinson's disease patients may provide important biomarkers for the early detection and monitoring of the disease, according to a new study.
  8. People with the movement disorder Parkinson's disease have a much higher risk of the skin cancer melanoma, and vice versa, a new study finds. While further research is needed into the connection, physicians treating one disease should be vigilant for signs of the other and counsel those patients about risk, the authors say.
  9. Alzheimer's disease and Parkinson's disease are different. But at the biochemical level, these two neurodegenerative diseases start to look similar. This is how Emory scientists landed on a potential drug target for Parkinson's.
  10. Parkinson's disease is commonly thought of as a movement disorder, but after years of living with the disease, approximately 25 percent of patients also experience deficits in cognition that impair function. A newly developed research tool may help predict a patient's risk for developing dementia and could enable clinical trials aimed at finding treatments to prevent the cognitive effects of the disease.

Please publish modules in offcanvas position.